Bridgewater Associates’s Dillards DDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,715
Closed -$5.89M 1062
2025
Q4
$5.89M Buy
9,715
+3,626
+60% +$2.28M 0.02% 481
2025
Q3
$3.74M Buy
+6,089
New +$3.15M 0.01% 558
2023
Q1
Sell
-4,263
Closed -$1.38M 765
2022
Q4
$1.38M Buy
+4,263
New +$1.39M 0.01% 594
2020
Q1
Sell
-5,872
Closed -$431K 461
2019
Q4
$431K Buy
+5,872
New +$416K ﹤0.01% 430
2015
Q4
Sell
-6,907
Closed -$604K 309
2015
Q3
$604K Buy
6,907
+4,500
+187% +$435K 0.01% 306
2015
Q2
$253K Buy
+2,407
New +$296K ﹤0.01% 301
2014
Q4
Sell
-2,200
Closed -$240K 358
2014
Q3
$240K Buy
+2,200
New +$256K ﹤0.01% 343

Other funds holding DDS

Bridgewater Associates's DDS Position: Q1 2026 in Review

Bridgewater Associates sold out of Dillards (DDS) in Q1 2026, closing a stake of 9,715 shares — an estimated $5.89M sold.

Bridgewater Associates first reported a position in DDS in Q3 2014 and held it in 7 quarters. The position peaked at $5.89M in Q4 2025. 316 funds tracked by Wall St. Rank hold DDS as of Q1 2026.

  • Bridgewater Associates reported no remaining Dillards position as of Q1 2026 after selling out during the quarter.
  • Bridgewater Associates sold 9,715 Dillards shares in Q1 2026, an estimated $5.89M.
  • Bridgewater Associates first reported a position in Dillards in Q3 2014 and held it in 7 quarters.
  • Bridgewater Associates's Dillards position peaked at $5.89M in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Dillards as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.